Phacilitate Leaders World 

Patient Access and Delivery of Advanced Therapies - Part One

Patient Access and Delivery of Advanced Therapies - Part One


An interview with Jacqueline Barry, chief Clinical Officer at Cell and Gene Therapy Catapult

Healthcare infrastructure and the patient journey are increasingly important factors for our industry. The delivery of advanced therapy treatments requires highly specialised skillsets and technology that cannot be found in all, indeed many, healthcare settings.

The UK is leading the way, forming a network of advanced therapies treatment centres; joint ventures set up to include industry, academic and NHS partners and funded by Innovate UK. Cell and Gene Therapy Catapult are supporting the development of this network and we spoke to Dr Jacqueline Barry, the Chief Clinical Officer at the CGT Catapult about the future of patient access to therapies and how industry sectors will work together to improve delivery.

Watch the video to find out the answers to these questions…

  1. Are specific centres of excellence the answer to patient access?
  2. What knowledge can clinics and industry share to expedite advanced therapies into mainstream healthcare?
  3. How should centres of excellence align their GMP requirements to match manufacturers?
  4. What role do treatment centres and their clinicians have in educating patients?



  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Anne-Virginie Eggimann
    bluebird bio
  • Great program, great people, great venue.
    Klaus Kühlcke
  • Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.
    Nathalie Clement
    Powell Gene Therapy Center, University of Florida
  • Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field.
    Dr James Trager
  • It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives.
    Kurt Gielen
    Chemelot Campus B.V.
  • Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.
    Steven Goodman